(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

WOMED RELEAF

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

WOMED RELEAF

ST13

US500000079373261

Class

5

Filing

79373261

Registration

7539892

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

04/03/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

03/07/2023

Registration date

10/22/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/22/2024

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

34

Owner location

FR

Examiner

LAM, HAI-LY HUYNH

Law office

N10

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Womed

Representatives

Carl Oppedahl Oppedahl Patent Law Firm LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical productspain relief medication; pharmaceutical preparations for use in the prevention and treatment of gynecological disorders; pharmaceutical preparationsanalgesic preparations; medical preparations for use in the prevention and treatment of gynecological disorders; medical preparationspreparation for the relief of pain; medicinal preparations for use in the prevention and treatment of gynecological disorders; medicinal preparationspreparation for the relief of pain; chemical preparations for medical usefor preventing and treating gynecological disorders; chemical preparations for medical usepreparation for the relief of pain; chemical preparations for pharmaceutical usefor preventing and treating gynecological disorders; chemical preparations for pharmaceutical usepreparation for the relief of pain; medical dressings; balms for medical use; pomades for medical use; sanitary preparations for medical use; surgical implants made of living tissue; biological implantsa vital processed human or animal connective tissue; biological implantsa biological skin tissue intended for subsequent implantation; biological implants for pharmaceutical purposesa vital processed human or animal connective tissue; biological implants for pharmaceutical purposesa biological bone tissue intended for subsequent implantation; surgical and medical dressings; wound dressings; medical adhesives for wound dressing; medical preparations for skin care in the form of gels

Publications

History of USPTO decisions and trademark events.

28 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/12/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/26/2025

FIMP

FINAL DISPOSITION PROCESSED

03/26/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/22/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/22/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

10/22/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/06/2024

PUBO

PUBLISHED FOR OPPOSITION

08/06/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/17/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/27/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/16/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

06/14/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/14/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

06/14/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/14/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/31/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/31/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/31/2024

RFNT

REFUSAL PROCESSED BY IB

01/02/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/12/2023

RFRR

REFUSAL PROCESSED BY MPU

12/12/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/08/2023

CNRT

NON-FINAL ACTION WRITTEN

12/07/2023

DOCK

ASSIGNED TO EXAMINER

12/05/2023

MAFR

APPLICATION FILING RECEIPT MAILED

08/01/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/26/2023

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

07/21/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/06/2023

Continuous trademark protection

Get notified about every new filing that threatens WOMED RELEAF or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.